| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 3 | |||
| NCT06858722 | Ripertamab for the Treatment of Chronic Inflammatory Demyelinating Polyneuropathy | Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) | Not Yet Recruiting |
| Phase 2/3 | |||
| NCT06373042 | Tirofiban for Successful Endovascular Stroke Thrombectomy | Stroke, Acute Ischemic | Not Yet Recruiting |
| NCT06684184 | Blinatumomab in Refractory Myasthenia Gravis (BLINA-MG) | Myasthaenia Gravis | Not Yet Recruiting |
| NCT06885762 | Efgartigimod for the Treatment of Guillain-Barré Syndrome | Guillain-Barre Syndrome (GBS) | Not Yet Recruiting |
| NCT07355257 | TELITACICEPT IN INFLAMMATORY MYOPATHIES(TELITACICEPT-IM) | Inflammatory Myopathy | Not Yet Recruiting |
| Phase 1/2 | |||
| NCT07372807 | Ripertamab for the Treatment of Myasthenia Gravis | Myasthenia Gravis (MG) | Not Yet Recruiting |
| NCT07685678 | Riptylimab for the Treatment of Optic Neuritis and Myelitis Spectrum Diseases | Neuromyelitis Optica Spectrum Disease (NMOSD) | Not Yet Recruiting |
| NCT07696377 | An Exploratory Study of Obinutuzumab β in the Treatment of Chronic Inflammatory… | Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) | Not Yet Recruiting |
| Not specified | |||
| NCT05891509 | DTI-guided Minimally Invasive Hematoma Evacuation for Intracerebral Hemorrhage | Stroke Hemorrhagic | Recruiting |
| NCT06388148 | Endovascular Treatment for eXtra-Large Ischemic Stroke | Stroke, Acute Ischemic | Recruiting |
| NCT06210633 | Prospective Registry of Endovascular Thrombectomy for eXtra-Large Ischemic Stroke | Acute Ischemic Stroke (AIS) | Recruiting |